TLR7 agonist SMIPs (Novartis)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTLR7 agonist SMIPs (Novartis)
Drug Alias NameTLR7 agonist small molecule immune potentiators (Novartis)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 7 agonists
TargetsToll like receptor 7
Therapy Area/IndicationsVaccinationCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Ag
Active IndicationsN/A
Inactive IndicationsVaccinationCommunicable Diseases

Other Information

ATC CodeN/A
Related LinksN/A